Compare Ginkgo Bioworks Holdings Inc (DNA) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Alliant Energy Corporation — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $590.53M), while Alliant Energy Corporation trades at $76.6 (market cap $19.71B). The key difference: Alliant Energy Corporation is far larger — about 33.4× Ginkgo Bioworks Holdings Inc's market cap, and Alliant Energy Corporation pays a 2.73% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | LNT | |
|---|---|---|
Market Cap | $590.53M | $19.71B |
Sector | Health | Utilities |
52-Week High | $16.14 | $78.03 |
52-Week Low | $5.48 | $61.85 |
Enterprise Value | $627.78M | $31.43B |
Dividend Yield | — | 2.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.
The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.
Alliant Energy (LNT) trades at $76.63, up 0.3% today, near the consensus price target of $76.50. The stock shows a bullish technical trend with strong moving average signals. Recent earnings have mostly beaten estimates, with Q1 2026 EPS of $0.82 exceeding expectations. The company's $13.4 billion clean energy investment plan aims to capitalize on data center demand and drive 5-7% annual earnings growth, supported by rising operating cash flow and a solid 18.58% net income margin.
LNT presents a balanced opportunity with steady utility earnings and growth initiatives, but faces risks from high capital expenditure and rising debt levels. Analyst sentiment is positive with a 52% buy rating, though the stock's valuation multiples like a P/E of 24.1 suggest limited near-term upside without significant earnings acceleration. Regulatory approvals and execution on its investment plan are critical for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
